David Schilansky

David Schilansky is the Chairman of the SequantrixTM Board. He is co-founder and CEO of Home Biosciences, the first biotech company dedicated to biotech venture building in Europe. David has more than twenty years of professional experience, mainly in the pharma and biotech industry. From 2011 to 2020, he co-headed DBV Technologies, transforming the company from a French research start-up to a unicorn about to launch a treatment of primary importance in the US. During this period, he led two IPOs on Euronext and Nasdaq, raising more than one billion US dollars in total. David began his career as an investment banker in M&A at Warburg Dillon Read. He also worked at Ipsen, from 2005 to 2011, where he held various roles in finance, including that of Group Chief Financial Officer, before moving to DBVT. David graduated from Paris Dauphine and Imperial College (London).